NewsBenzingaScotiabank mantiene il giudizio Outperform sul settore per Eli Lilly, alza il prezzo obiettivo a 1605 dollari Scotiabank mantiene il giudizio Outperform sul settore per Eli Lilly, alza il prezzo obiettivo a 1605 dollari Benzinga 2026.10.30 18:56 (GMT+0) Open on Benzinga Other news Tom Lee: AI Stock Selloff May Have Bottomed; Crypto Market's Reaction to Binance Incident Suggests Most Selling Pressure May Be Over Nasdaq-100 tumbles into its third correction this year as AI worries mount VanEck Executive: Citi Originally Planned to Launch Institutional Bitcoin Custody Last Week, Possibly Delayed by Binance Hack Ondo Launches MAG7Xon Tokenized Index, Combining Magnificent Seven With Spot Crypto ETFs $100 Invested In Cummins 5 Years Ago Would Be Worth This Much Today If You Invested $1000 In GE Aerospace Stock 5 Years Ago, You Would Have This Much Today
Tom Lee: AI Stock Selloff May Have Bottomed; Crypto Market's Reaction to Binance Incident Suggests Most Selling Pressure May Be Over
VanEck Executive: Citi Originally Planned to Launch Institutional Bitcoin Custody Last Week, Possibly Delayed by Binance Hack
